The 11LNCPS predicts not only prognosis but also immune cells’ responses to tumor cells, including decreased infiltrations of CD8+ T cells, macrophages, and DCs, as well as increased infiltrations of Th1, Th2, pro B cells. The gene discussed is CD8A; the disease is neoplasm.